COX inhibitor Deracoxib, Purity ≥98%

Cat. No.: X23-10-ZQ671

COX inhibitor Deracoxib, Purity ≥98%

Synonym: Deracoxib; 169590-41-4; Deramaxx; 4-(3-(Difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)-1H-pyrazol-1-yl)benzenesulfonamide; COX inhibitor

  • MDL: MFCD09837763
  • CAS Number: 169590-41-4
  • Compound CID: 3058754
Product Size
100 mg; 200 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Deracoxib, soluble in DMSO and ethanol and insoluble in water, blocks the COX enzymes from converting arachidonic acid to prostaglandins, thereby reducing inflammatory reactions.
Molecular Weight
397.37
Molecular Formula
C17H14F3N3O3S
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 74 mg/mL (186.22 mM); Water: Insoluble; Ethanol: 18 mg/mL (45.3 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Deracoxib can be used to investigate its COX-2 selective inhibition and anti-inflammatory properties, particularly in veterinary medicine.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.